Introduction
Methods
Subject recruitment
Clinical evaluation
Sleep evaluation and POSA classification
ArTH
Statistical analysis
Results
Prevalence of POSA
Characteristics | CC-POSA (n = 2115) | Si-POSA (n = 762) | Sp-POSA (n = 1353) | CC-NPOSA (n = 3633) |
---|---|---|---|---|
Demographic and clinical characteristics | ||||
Men, n (%) | 1739 (82.22) | 591 (77.56) | 1148 (84.85)### | 3074 (84.61)* |
In man, n (%) | 1739/4813 (36.13) | 591/4813 (12.28) | 1148/4813 (23.85)### | 3074/4813 (63.87)*** |
In women, n (%) | 376/935 (40.21) | 171/935 (18.29) | 205/935 (21.92)## | 559/935 (59.79)*** |
Age, yrs | 44 (36–54) | 43 (35–54) | 45 (36–54) | 43 (35–53)** |
BMI, kg/m2 | 26.47 (24.51–28.73) | 25.71 (23.72–27.72) | 26.98 (25.06–29.29)### | 27.51 (25.15–30.03)*** |
NC, cm | 40 (37–41) | 38.50 (36–41) | 40 (38–42)### | 40 (38–42.50)*** |
WC, cm | 95 (90–101) | 92.5 (88–98) | 97 (91–103)### | 98 (92–105)*** |
HC, cm | 100 (96–105) | 99 (95–103) | 101 (97–106)### | 103 (98–108)*** |
WHR | 0.94 (0.90–0.98) | 0.94 (0.90–0.97) | 0.95 (0.92–0.99)### | 0.96 (0.91–0.99)*** |
SBP, mmHg | 120 (118–132) | 120 (120–125) | 123 (120–135)### | 123 (120–136)*** |
DBP, mmHg | 80 (77–85) | 80 (79–80) | 80 (76–85)# | 80 (78–89)*** |
Hypertension, n (%) | 549 (25.96) | 166 (21.78) | 383 (28.31)# | 1021 (28.10)* |
Diabetes mellitus, n (%) | 185 (8.75) | 59 (7.74) | 126 (9.31) | 300 (8.26) |
CVD, n (%) | 150 (7.09) | 46 (6.04) | 104 (7.69) | 301 (8.29) |
MS, n (%) | 372 (17.59) | 110 (14.44) | 262 (19.36)# | 645 (17.75)*** |
Hyperlipidemia, n (%) | 369 (17.45) | 106 (13.91) | 263 (19.44) | 631 (17.37) |
Smoking, n (%) | 470 (22.22) | 165 (21.65) | 305 (22.54) | 685 (18.11)** |
Alcohol consumption, n (%) | 951 (44.96) | 337 (44.23) | 614 (45.38) | 2077 (57.17)*** |
Snoring score, point | 6 (5–8) | 6 (4–8) | 7 (5–9)### | 7 (5–9)*** |
ESS, point | 7 (3–11) | 7 (3–11) | 7 (3–12) | 9 (4–14)*** |
EDS, n (%) | 615 (29.08) | 198 (25.98) | 418 (30.89) | 1418 (39.03)*** |
Biochemical indicators | ||||
Fasting glucose, mmol/L | 5.25 (4.89–5.74) | 5.16 (4.86–5.60) | 5.29 (4.91–5.81)### | 5.35 (4.97–5.95)*** |
Glucose 120 min, mmol/L | 8.54 (6.28–11.84) | 8 (6.02–11.84) | 8.58 (6.48–11.90) | 7.78 (6.29–11.47) |
Fasting insulin, µU/mL | 10.74 (7.23–15.47) | 9.61 (6.54–13.61) | 11.33 (7.83–16.65)### | 12.68 (8.43–18.57)*** |
Insulin 120 min, µU/mL | 64.15 (39.35–119.50) | 60.80 (34.72–134.23) | 66.97 (40.52–115.75) | 71.49 (45.42–131)* |
HOMA-IR | 2.35 (1.49–3.65) | 2.14 (1.36–3.21) | 2.53 (1.58–4.03)### | 2.88 (1.72–4.54)*** |
TC, mmol/L | 4.71 (4.16–5.33) | 4.64 (4.12–5.28) | 4.75 (4.19–5.36)# | 4.81 (4.22–5.44)** |
TG, mmol/L | 1.63 (1.15–2.33) | 1.49 (1.06–2.07) | 1.71 (1.20–2.45)### | 1.74 (1.22–2.52)*** |
HDL, mmol/L | 1.02 (0.90–1.18) | 1.06 (0.90–1.23) | 1.01 (0.90–1.15)### | 1 (0.87–1.15)*** |
LDL, mmol/L | 2.94 (2.45–3.46) | 2.92 (2.40–3.40) | 2.96 (2.48–3.50) | 2.98 (2.47–3.53) |
ApoA-1, g/L | 1.05 (0.94–1.18) | 1.07 (0.95–1.19) | 1.04 (0.94–1.17) | 1.05 (0.95–1.18) |
ApoB, g/L | 0.84 (0.73–0.97) | 0.82 (0.71–0.95) | 0.85 (0.74–0.98)### | 0.87 (0.75–1)*** |
ApoE, mg/dL | 4.27 (3.46–5.26) | 4.10 (3.37–5.12) | 4.35 (3.51–5.38)## | 4.40 (3.58–5.58)*** |
Lp (α), mg/dL | 7.70 (3.90–16.10) | 8.60 (4.20–18.70) | 7.20 (3.80–14.70)## | 7.20 (3.80–15.35) |
ApoA/ApoB | 1.26 (1.05–1.51) | 1.30 (1.09–1.58) | 1.24 (1.04–1.48)### | 1.22 (1.03–1.46)*** |
PSG | ||||
Mild OSA, n (%) | 575 (27.19) | 449 (58.92) | 126 (9.31)### | 516 (14.21)*** |
Moderate OSA, n (%) | 633 (29.93) | 203 (26.64) | 430 (31.78)### | 540 (14.86)*** |
Severe OSA, n (%) | 701 (33.14) | 90 (11.81) | 611 (45.16)### | 970 (26.70)*** |
Extreme severe OSA, n (%) | 206 (9.74) | 20 (2.62) | 186 (13.75)### | 1607 (44.23)*** |
AHI, events/h | 25.80 (14.30–41.30) | 12.55 (7.90–22.03) | 34.30 (22.55–46.20)### | 50.60 (25.30–66.75)*** |
OAHI, events/h | 11.35 (4.75–22.37) | 5.22 (2.33–10.74) | 16.19 (8.35–26.89)### | 26.07 (10.32–44.20)*** |
Longest time of obstructive respiratory event, second | 45 (32.50–59) | 36.50 (25.50–51) | 49.50 (37–62.50)### | 57 (42–71)*** |
AHIREM, events/h | 31.10 (12.20–51.40) | 16 (5.60–33.70) | 40 (21.40–56.40)### | 51.40 (30–64.50)*** |
AHINREM, events/h | 25.20 (12.95–42.40) | 12.30 (7.03–22.68) | 33.60 (20.70–47.05)### | 49.80 (23–67.20)*** |
Supine AHI, events/h | 42.1 (24.40–60.30) | 21.40 (12.48–35.55) | 53.20 (38.10–65.70)### | 41.40 (5.90–67.50)*** |
Non-supine AHI, events/h | 7.80 (3.20–16.70) | 2.26 (1.17–3.46) | 13.42 (8.30–21.88)### | 46.35 (24.57–64.04)*** |
ODI, events/h | 26.20 (13.70–41.80) | 13 (8–23.25) | 33.90 (22.30–48.10)### | 49.80 (23.80–68.45)*** |
Mean SaO2, % | 95 (94–96) | 96 (94–96) | 94 (93–95)### | 94 (91–95)*** |
LSaO2, % | 82 (75–87) | 86 (81–89) | 80 (72–84)### | 74.50 (64–82)*** |
CT90, % TST | 2.84 (0.76–7.97) | 0.92 (0.23–3.42) | 4.48 (1.54–10.31)### | 9.61 (2.23–27.53)*** |
TST, min | 411.50 (347.48–452.50) | 410 (347–453) | 413.50 (347.45–452.50) | 425 (372–470.50)*** |
Supine Time, % TST | 73.39 (46.57–84.56) | 72 (49.79–83.75) | 73.77 (44.17–85.05) | 75.89 (38.43–85.85) |
Sleep efficiency, % | 94.52 (87.07–98.64) | 94.47 (86.50–98.85) | 94.59 (87.50–98.50) | 96.12 (88.81–99.33)*** |
N1, % TST | 16 (8.50–24.50) | 14.50 (7.30–23.63) | 16.40 (8.80–25.55)## | 15.40 (7.10–25.90) |
N2, % TST | 50.90 (38.10–59.40) | 50.70 (38.48–59.10) | 51 (37.75–59.65) | 51.30 (37.70–61.50) |
SWS, % TST | 12.50 (5.60–19.50) | 13.30 (6.38–20.40) | 11.90 (5.30–19.20)# | 10.80 (3.40–20.10)** |
REM, % TST | 10.40 (5.90–15) | 10.80 (6.07–15.20) | 10.30 (5.65–14.90) | 9.80 (5.70–14.20)* |
MAI, events/h | 21.70 (12.60–34.60) | 18.20 (11.10–28.30) | 24.40 (14–37.90)### | 27.30 (14.90–49.40)*** |
Components of ArTH score | ||||
AHI < 30 events/h, n (%) | 1208 (57.12) | 652 (85.56) | 556 (41.09)### | 1056 (29.07)*** |
LSaO2 > 82.5%, n (%) | 989 (46.76) | 503 (66.01) | 486 (35.92)### | 891 (24.53)*** |
Proportion of hypopneas > 58.3%, n (%) | 660 (31.21) | 301 (39.50) | 359 (26.53)### | 740 (20.37)*** |
Absolute fraction of hypopnoeas, % | 40 (17.31–64.77) | 47.17 (22.24–73.72) | 35.85 (15.48–60.25)### | 27.02 (8.20–51.98)*** |
ArTH Score, cmH2O | − 16.44 (− 21.62− [-11.78]) | − 12.43 (− 16.80− [− 8.49]) | − 18.53 (− 23.58− [− 14.18])### | -23.66 (-30.84-[-16.17])*** |
Proportion with ArTH score ≥ 2, n (%) | 973 (46) | 542 (71.13) | 431 (31.86)### | 830 (22.85)*** |
In male, n (%) | 750/1739 (43.13) | 410/591 (69.37) | 340/1148 (29.62)### | 616/3074 (20.04)*** |
In female, n (%) | 223/376 (59.31) | 132/171 (77.19) | 91/205 (44.39)### | 214/559 (38.28)*** |
Characteristics | APOC-POSA (n = 2465) | APOC I (n = 781) | APOC II (n = 1445) | APOC III (n = 239) | APOC-NPOSA (n = 3283) |
---|---|---|---|---|---|
Demographic and clinical characteristics | |||||
Men, n (%) | 2030 (82.35) | 605 (77.46) | 1213 (83.94) | 212 (88.70)### | 2783 (84.77)* |
In man (%) | 2030/4813 (42.18) | 605 (12.57) | 1213 (25.20) | 212 (4.41) | 2783 (57.82)*** |
In women (%) | 435/935 (46.52) | 176 (12.82) | 232 (24.81) | 27 (2.89) | 500 (53.48)** |
Age, yrs | 44 (35–54) | 43 (35–54) | 45 (36–55) | 42 (35–51)# | 43 (35–53)* |
BMI, kg/m2 | 26.49 (24.56–28.73) | 25.71 (23.72–27.71) | 26.73 (24.86–29.05) | 28.15 (26.18–30.46)### | 27.64 (25.17–30.07)*** |
NC, cm | 40 (37.50–41.50) | 38.50 (36–41) | 40 (38–42) | 41 (39–43)### | 40 (38–42.50)*** |
WC, cm | 96 (90–101) | 92 (88–98) | 96 (91–102) | 100 (96–107)### | 99 (93–105)*** |
HC, cm | 101 (97–105) | 99 (95–103) | 101 (97–106) | 104 (100–109)### | 103 (98–108)*** |
WHR | 0.94 (0.90–0.98) | 0.93 (0.89–0.97) | 0.95 (0.91–0.98) | 0.97 (0.93–1)### | 0.96 (0.92–0.99)*** |
SBP, mmHg | 120 (119–132) | 120 (119–125) | 122 (120–134) | 126 (120–138)### | 123 (120–136)*** |
DBP, mmHg | 80 (76–85) | 80 (79–81) | 80 (75–85) | 80 (76–88)### | 80 (78–89)*** |
Hypertension, n (%) | 630 (25.56) | 168 (21.51) | 401 (27.75) | 61 (25.52)## | 940 (28.63)** |
Diabetes mellitus, n (%) | 215 (8.72) | 60 (7.68) | 136 (9.41) | 19 (7.95) | 270 (8.22) |
CVD, n (%) | 176 (7.14) | 47 (6.02) | 118 (8.17) | 11 (4.60) | 275 (8.38) |
MS, n (%) | 444 (18.01) | 111 (14.21) | 260 (17.99) | 73 (30.54)### | 573 (17.45)*** |
Hyperlipidemia, n (%) | 441 (17.89) | 107 (13.70) | 262 (18.13) | 72 (30.13)### | 559 (17.03) |
Smoking, n (%) | 547 (22.19) | 170 (21.77) | 304 (21.04) | 73 (30.54)## | 608 (18.52)*** |
Alcohol consumption, n (%) | 1113 (45.15) | 348 (44.56) | 668 (46.23) | 97 (40.59) | 1915 (58.33)*** |
Snoring score, point | 6 (5–8) | 6 (4–8) | 6 (5–8) | 8 (5–9)### | 7 (5–9)*** |
ESS, point | 7 (3–12) | 7 (3–11) | 7 (2–12) | 9 (4–13)### | 9 (4–14)*** |
EDS, n (%) | 726 (29.45) | 198 (25.35) | 431 (29.83) | 97 (40.59)### | 1363 (41.52)*** |
Biochemical indicators | |||||
Fasting glucose, mmol/L | 5.25 (4.89–5.73) | 5.16 (4.85–5.59) | 5.27 (4.90–5.74) | 5.43 (4.93–6.21)### | 5.37 (4.98–5.96)*** |
Glucose 120 min, mmol/L | 8.25 (6.24–11.73) | 8.09 (6.07–11.82) | 8.35 (6.28–11.73) | 7.19 (6.32–10.58) | 7.97 (6.35–11.50) |
Fasting insulin, µU/mL | 10.90 (7.45–15.79) | 9.63 (6.56–13.70) | 11.11 (7.74–16.51) | 13 (9.95–20.19)### | 12.85 (8.46–18.65)*** |
Insulin 120 min, µU/mL | 67.86 (41.43–120.40) | 63 (35.57–138.90) | 66.79 (41.15–118.95) | 81.46 (63.62–123.78) | 71.01 (44.07–127.90) |
HOMA-IR | 2.38 (1.52–3.72) | 2.13 (1.33–3.21) | 2.45 (1.56–3.90) | 3.03 (2.08–5.02)### | 2.93 (1.72–4.56)*** |
TC, mmol/L | 4.72 (4.16–5.32) | 4.64 (4.11–5.28) | 4.76 (4.20–5.36) | 4.67 (4.08–5.29)# | 4.82 (4.22–5.47)*** |
TG, mmol/L | 1.65 (1.15–2.33) | 1.49 (1.06–2.08) | 1.70 (1.19–2.42) | 1.84 (1.27–2.55)### | 1.74 (1.23–2.54)*** |
HDL, mmol/L | 1.02 (0.90–1.18) | 1.06 (0.90–1.23) | 1.02 (0.90–1.16) | 0.98 (0.86–1.10)### | 1 (0.87–1.15)*** |
LDL, mmol/L | 2.94 (2.44–3.47) | 2.91 (2.40–3.40) | 2.97 (2.48–3.50) | 2.91 (2.43–3.52) | 2.99 (2.47–3.53)* |
ApoA-1, g/L | 1.05 (0.94–1.18) | 1.07 (0.95–1.19) | 1.04 (0.94–1.18) | 1.03 (0.93–1.15)# | 1.05 (0.95–1.18) |
ApoB, g/L | 0.84 (0.73–0.97) | 0.82 (0.71–0.95) | 0.85 (0.74–0.98) | 0.81 (0.73–0.99)## | 0.87 (0.76–1)*** |
ApoE, mg/dL | 4.28 (3.47–5.30) | 4.09 (3.39–5.12) | 4.32 (3.52–5.34) | 4.49 (3.60–5.85)### | 4.41 (3.59–5.60)*** |
Lp (α), mg/dL | 7.85 (3.90–16.30) | 8.60 (4.16–18.74) | 7.60 (3.90–15.10) | 6.80 (3.48–15.75)# | 7.12 (3.80–14.90)* |
ApoA/ApoB | 1.26 (1.06–1.50) | 1.30 (1.09–1.58) | 1.25 (1.04–1.48) | 1.23 (1.06–1.47)### | 1.21 (1.02–1.46)*** |
PSG | |||||
Mild OSA, n (%) | 611 (24.79) | 468 (59.92) | 143 (9.90) | 0 (0)### | 480 (14.62)*** |
Moderate OSA, n (%) | 750 (30.43) | 203 (25.99) | 547 (37.85) | 0 (0)### | 423 (12.89)*** |
Severe OSA, n (%) | 816 (33.10) | 90 (11.53) | 648 (44.85) | 78 (32.64)### | 855 (26.04)*** |
Extreme severe OSA, n (%) | 288 (11.68) | 20 (2.56) | 107 (7.40) | 161 (67.36)### | 1525 (46.45)*** |
AHI, events/h | 27.30 (15–43.20) | 12.20 (7.70–21.70) | 30.70 (20.60–41.80) | 61.10 (52.20–70.10)### | 52.10 (26–67.60)*** |
OAHI, events/h | 12.03 (5.19–23.70) | 4.95 (2.23–10.58) | 14.35 (7.76–24.01) | 34.51 (23.81–47.85)### | 27.27 (10.75–44.93)*** |
Longest time of obstructive respiratory event, second | 46 (33.50–60) | 36.50 (25.50–51) | 49 (36–62) | 57.50 (47–71.50)### | 57.50 (42.50–71.48)*** |
AHIREM, events/h | 33 (13.20–52.30) | 15.40 (5.60–33.60) | 37.10 (20.20–53.10) | 58.45 (46.18–70.80)### | 52.40 (30.90–65.10)*** |
AHINREM, events/h | 26.25 (13.90–43.43) | 12 (6.85–22.60) | 30.10 (19.39–42.70) | 59.65 (49.90–70.93)### | 51.55 (23.95–68.12)*** |
Supine AHI, events/h | 41.20 (24.10–59.65) | 20.90 (11.85–34.80) | 46.30 (32.80–60.30) | 71.30 (62.10–80.80)### | 43.70 (2–68.60)*** |
Non-supine AHI, events/h | 9.70 (3.76–20.57) | 2.30 (1.20–3.54) | 13.42 (8.78–20.93) | 36.36 (32.69–42.77)### | 49.59 (27.13–65.70)*** |
ODI, events/h | 27.30 (14.80–43.60) | 12.70 (7.70–22.80) | 30.70 (20.80–43.40) | 60.60 (48.70–72.65)### | 51.90 (25–69.50)*** |
Mean SaO2, % | 95 (93–96) | 96 (94–96) | 95 (93–96) | 93 (91–94)### | 93 (91–95)*** |
LSaO2, % | 82 (74–86) | 86 (81–89) | 81 (74–85) | 72 (64–78)### | 74 (64–82)*** |
CT90, % TST | 3.09 (0.83–8.57) | 0.90 (0.23–3.42) | 3.87 (1.32–8.85) | 13.49 (6.31–27.75)### | 10.72 (2.49–28.95)*** |
TST, min | 413.20 (352.10–453.50) | 410 (347.75–453) | 415.30 (352.43–452.50) | 417.50 (359–456.50) | 426 (372.50–471.90)*** |
Supine Time, % TST | 74.04 (47.91–84.90) | 72.35 (49.76–83.66) | 73.70 (44.92–85.16) | 80.06 (58.61–87.20)### | 75.53 (36.01–85.79)** |
Sleep efficiency, % | 94.46 (86.73–98.68) | 94.48 (86.52–98.86) | 94.61 (87.09–98.63) | 94.08 (84.56–98.43) | 96.26 (89.53–99.39)*** |
N1, % TST | 16.20 (8.50–25.20) | 14.60 (7.30–23.55) | 16.70 (8.80–26.30) | 16.40 (9.10–26.80)## | 15.20 (6.90–25.70)* |
N2, % TST | 50.80 (37.50–59.40) | 50.70 (38.60–59.05) | 50.80 (37.10–59.55) | 51.90 (35.40–60.20) | 51.30 (38.10–61.70)** |
SWS, % TST | 12.40 (5.50–19.60) | 13.20 (6.45–20.05) | 11.90 (5.20–19.40) | 10.40 (3.80–18.40)# | 10.80 (3.30–20.10)** |
REM, % TST | 10.30 (5.90–14.90) | 10.80 (6.05–15.20) | 10.20 (5.75–14.90) | 9.80 (6–14.30) | 9.80 (5.70–14.20)* |
MAI, events/h | 22.20 (12.70–35.30) | 18.25 (11.13–28.28) | 23.40 (13.50–36.05) | 33.90 (18.80–52.80)### | 27.80 (15–50.20)*** |
Components of ArTH score | |||||
AHI < 30 events/h, n (%) | 1361 (55.21) | 671 (85.92) | 690 (47.75) | 0 (0) | 903 (27.51) |
LSaO2 > 82.5%, n (%) | 1108 (44.95) | 518 (66.33) | 560 (38.75) | 30 (12.55) | 772 (23.52) |
Proportion of hypopneas > 58.3%, n (%) | 760 (30.83) | 313 (40.08) | 408 (28.24) | 39 (16.32) | 640 (19.49) |
Absolute fraction of hypopnoeas, % | 38.99 (16.67–63.95) | 47.83 (21.90–73.61) | 37.13 (16.04–61.51) | 27.40 (8.82–49.44) | 26.23 (7.66–50.75) |
ArTH Score, cmH2O | − 16.69 (− 22.29-[-11.97]) | − 12.32 (− 16.74− [− 8.44]) | − 17.85 (− 22.65− [− 13.37]) | − 25.73 (− 30.98− [− 21.97]) | − 24.15 (− 31.19− [− 16.50]) |
Proportion with ArTH score ≥ 2, n (%) | 1099 (44.58) | 559 (71.57) | 534 (36.96) | 6 (2.51) | 704 (21.44) |
In male, n (%) | 845/2030 (41.63) | 422/605 (69.75) | 418/1213 (34.46) | 5/212 (2.36) | 521/2783 (18.72) |
In female, n (%) | 254/435 (58.39) | 137/176 (77.84) | 116/232 (50) | 1/27 (3.70) | 183/500 (36.60) |
Comparison between POSA and NPOSA according to the CC and APOC criteria
ArTH
Predictors | n | OR (95% CI) | ||
---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||
CC | ||||
CC-NPOSA | 3633 | Reference | Reference | Reference |
Si-POSA | 762 | 7.302 (6.090–8.757)*** | 6.990 (5.791–8.437)*** | 3.542 (2.862–4.384)*** |
Sp-POSA | 1353 | 1.567 (1.357–1.809)*** | 1.546 (1.331–1.795)** | 1.043 (0.882–1.233) |
APOC | ||||
APOC-NPOSA | 3283 | Reference | Reference | Reference |
APOC I | 781 | 8.159 (6.791–9.802)*** | 7.828 (6.471–9.471)*** | 3.900 (3.141–4.842)*** |
APOC II | 1455 | 2.134 (1.853–2.457)*** | 2.098 (1.812–2.429)*** | 1.287 (1.091–1.518)** |
APOC III | 239 | 0.104 (0.046–0.236)*** | 0.118 (0.052–0.268)*** | 0.143 (0.062–0.330)*** |
POSA predictors
Predictors (n = 5748) | OR (95% CI) of CC | OR (95% CI) of APOC | ||
---|---|---|---|---|
Univariate regression analyses | Multivariate regression analyses | Univariate regression analyses | Multivariate regression analyses | |
Age | 1.006 (1.002–1.011)* | 1.006 (1.005–1.007)* | ||
Women | 1.189 (1.030–1.372)* | 1.181 (1.151–1.211)*** | ||
BMI | 0.936 (0.923–0.950)*** | 0.918 (0.916–0.920)*** | ||
NC | 0.929 (0.915–0.944)*** | 0.918 (0.915–0.920)*** | ||
WC | 0.971 (0.966–0.977)*** | 0.964 (0.964–0.965)*** | ||
HC | 0.969 (0.962–0.976)*** | 0.964 (0.963–0.966)*** | ||
ESS | 0.963 (0.954–0.972)*** | 0.954 (0.952–0.955)*** | ||
AHI | 0.965 (0.962–0.968)*** | 0.967 (0.960–0.973)*** | 0.957 (0.956–0.957)*** | 0.968 (0.961–0.974)*** |
ODI | 0.969 (0.967–0.972)*** | 0.964 (0.964–0.965)*** | ||
Mean SaO2 | 1.269 (1.239–1.299)*** | 1.099 (1.063–1.136)*** | 1.259 (1.254–1.263)*** | 1.086 (1.053–1.120)*** |
LSaO2 | 1.055 (1.050–1.061)*** | 1.060 (1.059–1.061)*** |
Predictors | n | OR (95% CI) | ||
---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||
CC-AHI | ||||
5 ≤ AHI < 15/h | 1091 | 8.630 (7.075–10.526)*** | 8.445 (6.859–10.397)*** | 4.174 (3.238–5.380)*** |
15 ≤ AHI < 30/h | 1173 | 9.056 (7.485–10.957)*** | 9.093 (7.460–11.083)*** | 4.818 (3.826–6.066)*** |
30 ≤ AHI < 55/h | 1671 | 5.574 (4.665–6.661)*** | 5.634 (4.685–6.775)*** | 3.643 (2.977–4.457)*** |
AHI ≥ 55 /h | 1813 | Reference | Reference | Reference |
Mean SaO2 | ||||
Mean SaO2 > 95% | 2412 | 5.795 (4.781–7.024)*** | 6.837 (5.569–8.394)*** | 1.495 (1.075–2.080)* |
94 ≤ Mean SaO2 ≤ 95 | 984 | 4.252 (3.435–5.264)*** | 4.787 (3.826–5.989)*** | 1.324 (0.965–1.816) |
92 ≤ Mean SaO2 < 94 | 1130 | 2.923 (2.370–3.606)*** | 3.165 (2.542–3.941)*** | 1.236 (0.939–1.627) |
Mean SaO2 < 92 | 1222 | Reference | Reference | Reference |
APOC-AHI | ||||
5 ≤ AHI < 15/h | 1091 | 6.606 (5.490–7.948)*** | 6.582 (5.415–7.999)*** | 3.400 (2.673–4.325)*** |
15 ≤ AHI < 30/h | 1173 | 9.175 (7.673–10.973)*** | 9.489 (7.869–11.443)*** | 5.127 (4.121–6.379)*** |
30 ≤ AHI < 55/h | 1671 | 4.997 (4.250–5.875)*** | 5.161 (4.359–6.110)*** | 3.399 (2.822–4.095)*** |
AHI ≥ 55 /h | 1813 | Reference | Reference | Reference |
Mean SaO2 | ||||
Mean SaO2 > 95% | 2412 | 5.256 (4.406–6.270)*** | 6.371 (5.268–7.706)*** | 1.443 (1.053–1.976)* |
94 ≤ Mean SaO2 ≤ 95 | 984 | 4.108 (3.370–5.008)*** | 4.700 (3.812–5.795)*** | 1.337 (0.989–1.807) |
92 ≤ Mean SaO2 < 94 | 1130 | 2.685 (2.215–3.256)*** | 2.960 (2.418–3.625)*** | 1.178 (0.910–1.527) |
Mean SaO2 < 92 | 1222 | Reference | Reference | Reference |